Clinical trials: Photorefractive Keratectomy
Photorefractive Keratectomy, Corneal De-epithelialization
Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy
Phase IV comparative, controlled, parallel group, open, randomized multicenter study to evaluate the efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo.
- Trial name
- PRO-037 (NCT04704518)
- Testing
- Sodium Hyaluronate Ophthalmic 0.4%, Trehalose 3% / Sodium Hyaluronate Ophthalmic 0.15%
- Where
- Mexico
- Volunteers
- 96 people
- Sponsor
- Laboratorios Sophia S.A de C.V.
Photorefractive Keratectomy, Myopia
Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control
Photorefractive Keratectomy (PRK) is a commonly performed corneal refractive surgery but has significant post-operative pain. Pain medications after PRK are typically opioid-acetaminophen combinations.
- Conditions
- Photorefractive Keratectomy, Myopia, Hyperopia
- Trial name
- NCT05477875
- Testing
- oral cannabinoid, oral codeine/acetaminophen
- Where
- United States
- Volunteers
- 35 people, healthy volunteers welcome
- Sponsor
- University of Florida
Photorefractive Keratectomy
Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
This is a randomized, double-masked, placebo-controlled study to determine the safety of pAF in patients who undergo PRK.
- Trial name
- NCT04281004
- Testing
- Amniotic Fluid (AFED), Saline Solution
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- University of Utah